India to Tanzania Pharmaceutical Export (2026) — $508.8M, 476 Suppliers | TransData Nexus

India to Tanzania Pharmaceutical Export (2026) — $508.8M, 476 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Tanzania

#	Formulation	Value	Share
1	Diclofenac Sodium with Paracetamol Table	$40.7M	8.0%
2	Metronidazole Tablets BP 200mg (230000 X	$40.1M	7.9%
3	Paracetomol Tablets BP (dolomol)(258713x	$32.6M	6.4%
4	Griseofulvin Tablets 500 MG BP (dermoful	$20.7M	4.1%
5	Combipack of Pantoprazole for Injection	$12.6M	2.5%
6	Lansoprazole Delayed-release Capsules USP 30	$11.4M	2.2%
7	Chlorphenamine Tablets BP (chlormine) (1	$10.4M	2.0%
8	Paracetamol Tablets BP 500mg (parafil)	$9.9M	1.9%
9	Captopril Tablets BP (capril-25) (23715x	$7.1M	1.4%
10	Dolutegravir Lamivudine and Tenofovir	$6.3M	1.2%
11	Hyoscine Butylbromide Injection BP 10 MG	$6.1M	1.2%
12	Gentamicin Eye/ear Drops Bp? 0.3 % W/v	$5.8M	1.1%
13	Azithromycin Oral Suspension 200 Mg/ 5	$5.3M	1.0%
14	Secnidazole Tablets BP 1000 MG (sac) (14	$5.3M	1.0%
15	Pharmaceutical Goods/harmless Medicines	$5.1M	1.0%

India exports 20+ pharmaceutical formulations to Tanzania with a combined trade value of $508.8M. Key products include Diclofenac ($40.7M), Metronidazole ($40.1M), Griseofulvin ($20.7M), Pantoprazole ($12.6M), Lansoprazole ($11.4M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 20,264 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Tanzania Trade Routes

1Diclofenac$40.7M 2Metronidazole$40.1M 3Griseofulvin$20.7M 4Pantoprazole$12.6M 5

Top Indian Exporters to Tanzania

1Lincoln Pharmaceuticals Ltd

$225.9M

2Medopharm

$41.2M

3Fourrts (india) Laboratories Private Limited

$23.6M

4Sparsh Bio-tech Private Limited

$10.8M

5Vansh Remedies

Port Analysis — India to Tanzania Pharmaceutical Shipments

Indian Export Ports

AHEMDABAD ICD4.1%

NHAVA SHEVA SEA (INNSA1)16.2%

CHENNAI AIR0.4%

KAMARAJAR PORT0.2%

JNPT/ NHAVA SHEVA SEA7.1%

Tanzania Import Ports

Dar Es Salaam27.8%

DAR ES SALAAM23.5%

DAR ES SALAM (DARESS16.0%

Lusaka2.9%

DODOMA0.2%

Trade Statistics

Total Value$508.8M

Shipments20,264

Indian Exporters476

Tanzania Buyers710

Avg Shipment$25K

Products14,207

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

India–Tanzania Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Tanzania has experienced significant growth over the past decade. In 2022, the total export value from India to Tanzania was approximately $508.8 million USD, encompassing 20,264 shipments. This robust trade relationship is supported by 476 Indian exporters and 710 Tanzanian buyers, with an average shipment value of $25,000. The primary regulatory authority overseeing this trade in Tanzania is the Tanzania Medicines and Medical Devices Authority (TMDA), which ensures the safety, quality, and efficacy of imported pharmaceutical products. (tmda.go.tz)

2India's Market Position

India holds a dominant position in Tanzania's pharmaceutical import market, supplying a substantial portion of the country's pharmaceutical needs. This strategic importance is underscored by the extensive network of Indian exporters and the diverse range of products offered, catering to various therapeutic areas critical to Tanzania's healthcare system.

3Recent Developments

Between 2024 and 2026, several key developments have influenced the India-Tanzania pharmaceutical trade. Notably, in April 2024, the TMDA updated its guidelines for the registration of medical devices and in-vitro diagnostic devices, streamlining the approval process for foreign manufacturers. This regulatory adjustment has facilitated increased market access for Indian pharmaceutical companies. Additionally, in June 2025, a bilateral trade agreement was signed between India and Tanzania, aiming to enhance trade relations and reduce tariffs on pharmaceutical exports, further strengthening the trade corridor.

Product Categories & Therapeutic Trends — India to Tanzania

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

India's pharmaceutical exports to Tanzania are predominantly in the form of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The top ten products exported in 2022 include:

1. Diclofenac Sodium With Paracetamol Tablets ($40.7M, 8.0%)

2. Metronidazole Tablets BP 200MG ($40.1M, 7.9%)

3. Paracetamol Tablets BP (Dolomol) ($32.6M, 6.4%)

4. Griseofulvin Tablets 500 mg BP (Dermoful) ($20.7M, 4.1%)

5. Combipack of Pantoprazole For Injection ($12.6M, 2.5%)

6. Lansoprazole Delayed-Release Cap USP 30 ($11.4M, 2.2%)

7. Chlorphenamine Tablets BP (Chlormine) ($10.4M, 2.0%)

8. Paracetamol Tablets BP 500MG (Parafil) ($9.9M, 1.9%)

9. Captopril Tablets BP (Capril-25) ($7.1M, 1.4%)

10. Dolutegravir Lamivudine and Tenofovir ($6.3M, 1.2%)

These products align with Tanzania's healthcare needs, addressing prevalent conditions such as pain, infections, gastrointestinal disorders, and chronic diseases.

2Emerging Opportunities

The expiration of patents for several blockbuster drugs presents opportunities for Indian pharmaceutical companies to introduce generic versions in Tanzania. Additionally, the growing demand for biosimilars in the region offers a promising avenue for expansion. Indian exporters can also explore new therapeutic areas, such as oncology and immunology, to meet the evolving healthcare needs of the Tanzanian population.

3Demand Drivers

Tanzania's disease burden, characterized by high rates of infectious diseases like malaria and HIV/AIDS, drives the demand for pharmaceutical imports. The aging population and increasing prevalence of non-communicable diseases, such as diabetes and hypertension, further contribute to the rising need for medications. Government initiatives to improve healthcare infrastructure and spending are also significant factors influencing import demand from India.

EXPORT_POLICY

TransData Nexus Research · DGFT trade data analysisMar 2026

FAQ — India to Tanzania Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Tanzania?

India exported pharmaceuticals worth $508.8M to Tanzania across 20,264 verified shipments.

Who are the top Indian pharmaceutical exporters to Tanzania?

1. LINCOLN PHARMACEUTICALS LTD — $225.9M. 2. MEDOPHARM — $41.2M. 3. FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED — $23.6M. Total: 476 suppliers.

Which companies in Tanzania import pharmaceuticals from India?

1. HEKO PHARMACY LTD — $199.2M. 2. M/S. PLANET PHARMACEUTICAL LTD — $40.1M. 3. MEDICAL STORES DEPARTMENT — $22.5M. 710 buyers total.

What pharmaceutical products does India export most to Tanzania?

1. Diclofenac Sodium with Paracetamol Table ($40.7M, 8.0%); 2. Metronidazole Tablets BP 200mg (230000 X ($40.1M, 7.9%); 3. Paracetomol Tablets BP (dolomol)(258713x ($32.6M, 6.4%); 4. Griseofulvin Tablets 500 MG BP (dermoful ($20.7M, 4.1%); 5. Combipack of Pantoprazole for Injection ($12.6M, 2.5%)

Which ports handle pharmaceutical shipments from India to Tanzania?

Export: AHEMDABAD ICD, NHAVA SHEVA SEA (INNSA1), CHENNAI AIR, KAMARAJAR PORT, JNPT/ NHAVA SHEVA SEA. Import: Dar Es Salaam, DAR ES SALAAM, DAR ES SALAM (DARESS, Lusaka, DODOMA.

Why does Tanzania import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $508.8M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Tanzania?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Tanzania pharmaceutical trade?

$25.1K per consignment across 20,264 shipments.

How many Indian pharmaceutical companies export to Tanzania?

476 Indian companies. Largest: LINCOLN PHARMACEUTICALS LTD with $225.9M.

How can I find verified Indian pharmaceutical suppliers for Tanzania?

TransData Nexus covers 476 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Tanzania identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 20,264 verified shipments from 476 Indian exporters to 710 Tanzania buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

476 Exporters

710 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Tanzania Pharmaceutical Export

Top Pharmaceutical Formulations — India to Tanzania

Top Pharmaceutical Products — India to Tanzania Trade Routes

Top Indian Exporters to Tanzania

Port Analysis — India to Tanzania Pharmaceutical Shipments

Indian Export Ports

Tanzania Import Ports

Trade Statistics

Other Destinations

India–Tanzania Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

3Recent Developments

Top Tanzania Buyers from India

Product Routes

Full Dataset Access

Tanzania Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Tanzania

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Tanzania

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Tanzania Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Tanzania for Indian Pharma

1Market Size & Growth

2Healthcare System